We are live on ! Find out more
NA

Nordwand Advisors Portfolio holdings

AUM $572M
1-Year Est. Return 23.09%
This Fund
S&P 500
This Quarter Est. Return
-4.32%
1 Year Est. Return
+23.09%
3 Year Est. Return
+66.91%
5 Year Est. Return
10 Year Est. Return
AUM
$505M
AUM Growth
-$78.7M
Cap. Flow
-$31.9M
Cap. Flow %
-6.32%
Top 10 Hldgs %
90.36%
Holding
130
New
11
Increased
7
Reduced
27
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 45.62%
2 Healthcare 40.03%
3 Technology 7.32%
4 Consumer Discretionary 1.68%
5 Industrials 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
101
PayPal
PYPL
$49.5B
$8.3K ﹤0.01%
142
ABNB icon
102
Airbnb
ABNB
$89.4B
$6.86K ﹤0.01%
50
QQQ icon
103
Invesco QQQ Trust
QQQ
$469B
$6.81K ﹤0.01%
19
PFE icon
104
Pfizer
PFE
$143B
$6.63K ﹤0.01%
+200
New +$7.07K
XSMO icon
105
Invesco S&P SmallCap Momentum ETF
XSMO
$3.09B
$6.55K ﹤0.01%
135
GOOGL icon
106
Alphabet (Google) Class A
GOOGL
$4.57T
$5.37K ﹤0.01%
41
SOPH icon
107
SOPHiA GENETICS
SOPH
$477M
$5.09K ﹤0.01%
2,000
UL icon
108
Unilever
UL
$137B
$4.74K ﹤0.01%
85
IPVF.WS
109
DELISTED
InterPrivate III Financial Partners Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
IPVF.WS
$4.55K ﹤0.01%
130,000
+10,000
+8% +$434
GBIL icon
110
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.57B
$4.5K ﹤0.01%
45
XYZ
111
Block Inc
XYZ
$48.9B
$4.43K ﹤0.01%
100
DOCU
112
DocuSign
DOCU
$10.5B
$4.2K ﹤0.01%
100
DOW icon
113
Dow Inc
DOW
$21.6B
$3.97K ﹤0.01%
+77
New +$4.13K
XPEV icon
114
XPeng
XPEV
$11.8B
$3.67K ﹤0.01%
200
LENZ
115
LENZ Therapeutics
LENZ
$157M
$2.48K ﹤0.01%
143
ARKK icon
116
ARK Innovation ETF
ARKK
$5.84B
$1.98K ﹤0.01%
50
VOO icon
117
Vanguard S&P 500 ETF
VOO
$993B
$1.96K ﹤0.01%
5
GETR.WS
118
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$1.75K ﹤0.01%
116,461
EEM icon
119
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$1.67K ﹤0.01%
44
EGRX
120
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.58K ﹤0.01%
100
AIH
121
DELISTED
Aesthetic Medical International Holdings
AIH
$1.28K ﹤0.01%
2,000
VO icon
122
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$1.04K ﹤0.01%
20
VB icon
123
Vanguard Morningstar Small-Cap ETF
VB
$80.7B
$567 ﹤0.01%
3
OPEN icon
124
Opendoor
OPEN
$3.8B
$528 ﹤0.01%
207
AHCO icon
125
AdaptHealth
AHCO
$1.47B
-300
Closed -$3.65K

Similar funds

Nordwand Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Nordwand Advisors held 130 positions worth $505M, down 13% from $583M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Nordwand Advisors withdrew a net $31.9M in Q3 2023, closing 6 positions and reducing 27 holdings. Its most notable exit was InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant, an estimated $563K position sold in full.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 40% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Nordwand Advisors opened a new position in GSK worth $1.7M.

  • Nordwand Advisors's largest Q3 2023 buy was GSK: 47,019 shares worth $1.7M.
  • Nordwand Advisors added most to M.D.C. Holdings, Inc. in Q3 2023, an estimated $1.03M increase.
  • Nordwand Advisors's biggest Q3 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $10.8M.
  • Nordwand Advisors fully exited InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant in Q3 2023, selling an estimated $563K.
  • Nordwand Advisors's ten largest holdings make up 90% of its $505M portfolio in Q3 2023.
  • Nordwand Advisors opened 11 new positions and closed 6 in Q3 2023.
  • Nordwand Advisors's portfolio value fell 13% quarter-over-quarter to $505M.

Based on Nordwand Advisors's 13F filing for Q3 2023, filed 27 Oct 2023.